The present invention relates to compounds described herein Formula (I) and pharmaceutical acceptable salts thereof, which modulate the activity of calcium release- activated calcium (CRAC) channel. The invention also describes the compounds of Formula (I)and pharmaceutical compositions containing such compounds thereof for treating, managing, and/or lessening the severity of diseases, disorders, syndromes or conditions associated with the modulation of calcium release-activated calcium (CRAC) channel.
本发明涉及式(I)描述的化合物以及其中医药可接受的盐,这些化合物能够调节
钙释放激活
钙(CRAC)通道的活性。该发明还描述了式(I)的化合物以及包含这些化合物的药物组合物,用于治疗、管理和/或减轻与调节
钙释放激活
钙(CRAC)通道相关联的疾病、障碍、综合征或状况的严重性。